Active Pharmaceutical Ingredients Market is expected to grow at a CAGR of 6.7% during the forecast period of 2018 to 2025.
Active pharmaceutical ingredients (API) is the most important component of a finished pharmaceutical product in terms of clinical efficacy and value. Therefore, the API market has become a global business in last decades owing to tremendous use of drugs and use of biologics in the treatment of diseases. For instance, Europe have a strong API manufacturing base due to presence of highly qualified, skilled, and experienced staff. European manufacturers strictly follow Good Manufacturing Practices (GMP) and provide healthcare professionals and patients with quality pharmaceutical ingredients for medicines promoting the quality of life.
Increasing geriatric population, rise in healthcare expenditure, increase in number of hospitals, increasing awareness about diseases, and increasing prevalence of lifestyle diseases and chronic diseases are some of the major factors that drive the API market. Moreover, increase in demand for efficient drugs, increasing use of advanced technology in therapeutics and evolution of personalized medicines would also boost the market in near future. The market faces challenges such as high investment and expiration of patents which may hamper the growth of the market. APIs outsourcing by top players of the industry in emerging countries is consistently witnessed trend in the market. This offers growth opportunities for developing countries such as China, India, and Brazil.
The report provides detailed qualitative and quantitative analysis of the global active pharmaceutical ingredients market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely API, type of drugs, market players, and application in each of the major regions of the world.
Active Pharmaceutical Ingredients Market Player Analysis -
The report presents detailed analysis of major players operating in global active pharmaceutical ingredients market. Some of the key players operating in the market are BASF SE, Novartis AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Mylan N.V., Actavis Plc, Lonza Group AG, and Dr. Reddy's Laboratories.
The active pharmaceutical ingredient market segmented based on API, type of drugs, market players, application, and geography. Based on API, the market is bifurcated into chemical API and biological API. Based on type of drugs, the market is classified as generic, innovative and OTC drugs. Market players in the market are segmented as merchant manufacturers and captive manufacturers. Active pharmaceutical ingredients are used in variety of applications such as Radiology/Interventional Radiology, Cardiology, Orthopedics, Oncology, Vascular, Neurology, Others. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, and Rest of the World.
Active Pharmaceutical Ingredients Market Segmentation
• Chemical API
• Biological API
By Type of Drugs
• Over-the-counter (OTC) drugs
By Market Players
• Merchant (contract) manufacturer
• Captive (In-house) manufacturer
• Radiology/Interventional Radiology
• North America
o Rest of Europe
o Rest of Asia-Pacific
• Rest of the World
o Middle East
o Latin America
Active Pharmaceutical Ingredients Market Key Players
• BASF SE
• Novartis AG
• Pfizer, Inc.
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Ltd.
• Mylan N.V.
• Actavis plc.
• Lonza Group AG
• Dr. Reddy's Laboratories
• Hospira Inc.